Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids
Open Access
- 1 May 1997
- Vol. 52 (5), 476-482
- https://doi.org/10.1136/thx.52.5.476
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patientsThorax, 1997
- Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children.Thorax, 1996
- A low dose ACTH test to assess the function of the hypothalamic–pituitary–adrenal axisClinical Endocrinology, 1996
- New perspectives on inhaled drug delivery and systemic bioactivity.Thorax, 1995
- Growth and the growth hormone axis in prepubertal children with asthmaThe Journal of Pediatrics, 1995
- High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic SocietyEuropean Respiratory Journal, 1994
- Effect of beclomethasone dipropionate on bone mineral content assessed by X-ray densitometry in asthmatic children: a longitudinal evaluationEuropean Respiratory Journal, 1994
- Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group.Thorax, 1993
- The Effect of Long-Term Glucocorticoid Therapy on Pituitary–Adrenal Responses to Exogenous Corticotropin-Releasing HormoneNew England Journal of Medicine, 1992
- THE EFFECT ON GROWTH OF CHILDHOOD ASTHMAActa Paediatrica, 1981